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1. Introduction 
It is generally believed that platelet aggregation 
and secretion depend on the simultaneous production 
of energy [ 11. ~lnmediately after inducti of these 
processes, both lactate production and mitochondrial 
oxygen consumption increase [2,3]. Consequently, 
more ATP is generated and since the level of ATP 
involved in metabolism (metabolic-ATP) changes 
only slightly, it has been assumed that ATP is con- 
sumed in processes retated to platelet fullctiol~ [ 1,4]. 
Inhibition of energy production lowers the metabolic- 
ATP level gradually with a sequential disappearance 
of the platelets’ ability to perform secretion, aggrega- 
tion and shape change. Specific threshold levels of 
nletaboli~-ATP were therefore postulated for each 
platelet function with shape change, aggregation and 
secretion requiring increasing amounts of metabolic- 
ATP [5]. Although the energy balance in non-stimulated 
platelets clearly affects subsequent platelet behaviour, 
it is difficult to assess the role of metabolic energy 
during platelet function. It is, for example, unclear 
whether the increase in energy production during 
platelet function directly supports these functions or 
merely reflects a disturbance in control mechanisms 
that regulate energy metabolism. This paper demon- 
strates that aggregation and Ca2’ secretion depend 
mainly on the energy state of the platelet at the 
moment of stimulation with only minor involvement 
of energy production during these platelet functions, 
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2. Materials and methods 
Freshly drawn venous blood (160 ml portions} was 
collected from healthy volunteers into citrate (1 .O vol. 
130 mM trisodiulll citrate). After- centrifugation 
(200 X g, 15 min room temp.), the supernatant, 
platelet-rich plasma, was incubated with 0.4 PM 
[U-r4C] adenine (spec. act. 286 mCi.nmol-‘, Amersham, 
Arlington Heights, IL, code CFA, 436) for 30 min at 
37°C to label the metabolic adenine nucleotides [6f. 
The adenine nucleotideslocalized in the dense granules 
and released during secretion are not labelled in this 
short incubation period [7]. The platelets were then 
isolated by gel filtration on a Sepharose 2B column 
(20 X 3 cm, 22°C) [X] equilibrated with a Sr2+and 
albuI~lin-containing, Ca”-free Tyrode’s solution [9] 
without glucose. In some experiments 8.2 ~g.nil-’ 
antimycin A (Sigma, St Louis, MO) was included 
in the buffer. After gel filtration (completed within 
20-30 nun) 1.9 mM MgC12, 0.05 mM CaCl, and 
1 mM glucose were added. This provided the bivalent 
cations which are essential to aggregatio~l and enabled 
measurement of Ca2+ secretion with a Ca2+ electrode 
in a range where electrode output in linear with 
respect to Ca2+ concentration [IO] . Platelets do not 
lose their functional ability during gel filtration in 
glucose-free media provided that sufficient glucose is 
added some few minutes prior to induction of fun~tio~l, 
The addition of 1 mM glucose restores energy produc- 
tion completely [ 1 I] and on the other hand, this 
concentration was sufficiently low to enable rapid 
suppression of glucose utilization by adding an excess 
of the competitive inhibitor 2-deoxyglucose [12] . 
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Platelet aggregation and secretion was measured in 
a 3 ml cuvette (at 37°C) equipped with a device for 
continuous measurement of light transmission (aggrega- 
tion) and extracellular Ca’+ content (secretion), using 
a Cazc electrode (type F 2 112, Radiometer, Copen- 
hagen 10) with a pH combination electrode (type 
S-9OOC, Sensorex, Irvine, CA) as a reference. Response 
time of the CaZC electrode was <I s; interference of 
pH changes was <S%. The electrode output was con- 
ditioned by a specially constructed alnpli~er system 
(Instech Laboratories, Philadelphia, PA) equipped 
with a digital voltmeter over a + 1999 mV range. A 
multiplexer pen lift controller permitted recording of 
light transmission and Ca2* electrode output on a 
single channel (Hewlett-Packard 7123 A) 1 V full 
scale recorder with 8 s intervals. The suspensions were 
stirred at 900 rev./min f13j. Samples were collected 
before and during induction of platelet function with 
thrombin for measurement of “C-radioactivity in 
ethanol-soluble adenine nucleotides and lactate in 
extracts of 1 vol. platelet suspension and 2 vol. 
7.7 mM EDTA in 96% ethanoI kept at 0°C [6]. 
3. Results and discussion 
In human platelets metabolic ATP is the only 
known intermediate for energy transduction from 
sites of generation to sites of utilizatiorl [l J. Its level 
can be monitored accurately by measuring Ci4CJATP 
in extracts of [14C]adenine-labelled platelets [6]. 
Addition of 5 NIH-U.ml-* of tl~rombin to platelets 
induced aggregation and rapid secretion of Ca** 
(fig.1). Probably as a result of a sudden increase in 
energy consumption the [14C]ATP level fell. Then, as 
lactate production and mitochondrial respiration rose 
(data not shown), a new equilibrium was established 
by an increased ATP productions in glycolysis and 
oxidative phosphorylation. When the platelet SW- 
pension contained antimycin A, which blocks mito- 
chondrial ATP production, thrombin caused a greater 
fall in the [14C]ATP level indicating that glycolysis 
alone could not keep up with the increased demand for 
ATP (fig.2A). ~thou~l energy generation thus 
clearly was suboptimal, aggregation and Ca’*secretion 
were not affected (fig.2A). An abrupt block in glyco- 
lytic energy production could be induced by a mixture 
Fig.1. Platelet aggregation, Ca2* secretion and [“‘CJATP 
radioactivity during platelet-thrombin interaction. 14C- 
labelled, gel-filtered platelets were stirred at 37°C in the 
cuvette described in section 2. Thrombin (5 NIH-U.ml-’ ) 
was added at the arrow and the changes in the extracellular 
calcium concentration (upper panel, PM), /“4C]ATP 
(closed circles, % of total ‘~~-radioactivity) and tight trans- 
mission (arbitrary units, transmission increases upwards with 
the degree of platelet afrgregation) are shown. The open 
circles show the % ATP radioactivity in the same platelet 
suspension stirred without thrombin. 
Fig.2 
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Fig.2. Platelet aggregation, Ca2+ secretion and [14C]ATP 
radioactivity in antimycin A-treated platelets upon addition 
of 2deoxyglucose + glucono-lactone and thrombin. 14C- 
labelled platelets were gel filtered, incubated (for 20 min, 
37°C) in the presence of 8.2 pg.ml-’ antimycin A and 
finally stirred in the cuvette at 37°C. Shown are the responses, 
addition (arrow) of 5 U.n&’ of thrombin (A), a mixture of 
30 mM 2deoxyglucose and 10 mM gluconod-lactone (B); 
simultaneously added thrombin and 2deoxyglucose_glucono- 
6-lactone (C); and after an interval between addition of 
2-deoxyglucosegluconoq-lactone (left arrow) and thrombin 
(right arrow) of 15 s (D); 45 s (E) and 75 s (I;). Platelet 
concentration was 3.2 X lOa cells.ml-’ Further details are 
described in fig.1. 
of 2-deoxyglucose and glucono-&-lactone* to anti- 
mycin A-treated platelets (fig.2B). This mixture 
inhibited lactate production within 5 s and led to a 
rapid decrease in [ 14C] ATP in antimycin A-treated 
platelets (fig.2B). When 5 U.ml-’ of thrombin was 
included in this mixture an even more rapid fall in 
[14C]ATP was observed. Ca’+secretion and immediate 
aggregation, however, occurred normally within the 
first 2 min after thrombin addition. Further aggrega- 
tion diminished and was then followed by a secondary 
increase in light transmission (fig.2C). When the time 
interval between addition of the 2-deoxyglucose + 
gluconolactone mixture and of thrombin was increased, 
Ca’+ secretion and aggregation gradually decreased 
and were completely blocked with a 75 s time inter- 
val (fig.2D-F). 
The lag time between addition of thrombin and 
appearance of aggregation and Ca2+ secretion was 
increased by lowering the thrombin concentration, 
and the inhibition by the metabolic blockers was 
more prominent. By adding inhibitors and varying 
amounts of thrombin simultaneously, these functions 
disappeared at 0.5 U.ml-’ of thrombin or lower; with 
a 20 s interval between addition of inhibitors and 
thrombin abolishment of the platelet response was 
already present at 1 .O U.ml-’ of thrombin. 
Because of the rapid hydrolysis of gluconolactone 
in solution, pH fell from 7.2 to 6.8 during each of the 
experiments recorded in fig.2. Control studies carried 
out at a starting pH of 6.8 showed that the results 
were not affected by this change in pH. The instability 
of gluconolactone also prevented removal of 
contaminating Ca2+ (fig.2B). Addition of each metabolic 
inhibitor alone neither affected the metabolic ATP 
level nor platelet function. 
The second phase in the change in light transmission 
(fig.2CE) was not affected by prior addition of 
100 yg.ml-’ apyrase (Sigma, St Louis), which rapidly 
removed ADP secreted from the platelets and prevents 
subsequent ADPPplatelet interaction. The thrombin 
inhibitor hirudin (5 U.ml-‘, Pentapharm, Basel), when 
added 10 s after thrombin, completely abolished this 
* 2deoxy-D-glucose is a competitive inhibitor of glucose 
transport and phosphorylation [14,15]. The phosphorylation 
product, 2-deoxyglucosed-phosphate, competitively blocks 
glucose phosphate isomerase activity [ 151. Glucono-6-lactone 
inhibits glycogen phosphorylase and prevents glycogen 
degradation [16,17] 
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‘second wave’. During this ‘second wave’ both energy 
production and [14C]ATP catabolism were absent. 
This phenomenon may therefore reflect an energy- 
independent agglutination process as induced by 
bovine factor VIII [ 181, ristocetin [19] or polylysine 
[20] rather than aggregation [ 11. Its sensitivity to 
hirudin indicates that it is thrombin-mediated and 
therefore might consist in trapping of platelets by 
fibrin formed by action of thrombin on fibrinogen 
secreted from the platelets [2 11. 
These results indicate that Ca*+ secretion and 
aggregation are independent of simultaneous energy 
production. However, at the moment of stimulation 
of a sufficiently high metabolic ATP level, i.e., 
energy potential, is essential for optimal platelet 
behaviour since these functions gradually disappear 
when stimulation takes place at a lower ATP level. 
The parallel inhibition of Ca2+ secretion and aggrega- 
tion contradicts our proposed differences in energy 
requirement of these processes [5], although the use 
of a potent stimulator such as thrombin might well 
mask more subtle differences in energy requirement 
as revealed with weak inducers such as ADP. The 
present data, however, indicate that it is not the 
degree of metabolic inhibition but the time between 
blocking of energy metabolism and stimulation of 
the platelets that is the crucial factor. 
The role of metabolic ATP was further evaluated 
Table 1 
Role of energy production during thrombin-induced Ca2+ secretion and aggregation 
Conditions Energy status Ca’+ secretion Aggregation (arbitrary units) 
(ATP equiv.: ~mo1.min~‘.10~” cells) 
Produc- 
tion 
+ Thrombin 
- 2DG + GLAC 
10.2 + 1.2 
+ Thrombin 
+ 2DG + GLAC 
0 
- Thrombin 
+ 2DG + GLAC 
0 
Fall in 
ATP + ADP 
Con- k, 
sump- (s-’ ) 
tion 
Amount 
(p at lo-” cells) 
8.9 * 1.5 19 0.022 f 0.005 14.48 + 2.67 
16.3 + 3.6 16 0.022 + 0.004 14.88 * 3.18 
4.7 + 0.5 5 0 0 
Initial velocity Maximum 
(min“ ) first phase 
13.2 0.9 18.5 +_ 2.0 
13.9 i 1.4 9.9 r 0.7 
0 0 
Energy production and steady-state levels of [‘YZ]ATP and [14C]ADP were measured during thrombin (5 U.ml-‘)-induced Ca’+ 
secretion and aggregation in the presence of antimycin A and with and without simultaneous addition of 2-deoxyglucose + 
gluconod-lactone (2DG + GLAC). Since antimycin A was present, ATP production could be calculated from lactate formation 
which was measured at 4 min intervals over a 30 min period after thrombin addition. Since lactate production remained linear 
over this period, values were extrapolated to t = 0 (thrombin addition) and compared with the levels of [14C]ATP and (“‘CIADP 
measured at 5 s intervals between 5 s and 30 s after thrombin addition. “‘C-Radioactivity data were converted into absolute amounts 
on the basis that the 80% of total “‘C-radioactivity found in ATP in normal platelets equals the amount of metabolic ATP, that is 
3.5 fimol.lO-” platelets [22,23] Energy data are expressed in ATP equivalents [24] reflecting an energy yield of 2 eqmv. !or 
conversion of ATP to AMP and of 1 equiv. for conversion of ATP to ADP. Energy consumption was taken as the sum of produc- 
tion and fall in [14C]ATP + ADP 
The kinetics of Cal+ secretion measured with the Ca*+ electrode followed the model proposed [25] consisting of 3 phases: an 
initial lag phase (k,-phase), followed by an exponential phase in which most of the Ca ‘+ iS secreted and finally a slow linear k,- 
phase. The rate constant of the second phase (k,) was measured with a 15 s interval between addition of 2DG + GLAC and 
thrombin (fig.2D) to avoid interference of Ca*+ contaminated 2DG + GLAC (fig.2B). k, data at longer time intervals were within 
the same range (0.023 * 0.005). The amount of Ca*+ secreted (with simultaneous additions of 2DG + GLAC and thrombin) was 
corrected for the Ca2+ contained in 2DG + GLAC 
Aggregation velocity was calculated over the first 30 s after thrombin addition. Since the absorbance of a platelet suspension is 
linear with cell concentration only at low platelet counts (<l X lo* .ml-’ ) data were gathered from suspensions with similar cell 
concentrations 
Data reflect mean f SD from 4-7 experiments. Platelet concentrations were 3.2-3.5 X lo8 cells.ml-’ 
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by calculating the energy made available by glyco- 
lysis and the fall in [14C]ATP + ADP during the first 
30 s of interaction between thrombin in antimycin 
A-treated platelets. In the presence of 2-deoxyglucose 
+ ~uconolactol~e almost the same amount of energy 
was liberated as in the absence of these inhibitors 
(16 compared to 19 pmol ATP equiv. . min-’ .10-r' 
cells, table 1). If the energy consumption in non- 
stimulated platelets (-5 /_mlol ATP equiv. . min-” .10-l’ 
cells) is temporarily lowered, as occurs during starva- 
tion and for aggregation at normal velocity [f 11, 
enough energy may be made available for secretion of 
normal amounts of Ca2+ and for aggregation of 
normal velocity. At a lower [r4C]ATP level thrombin 
induced less energy liberation leading to less Ca2+ 
secretion and slower aggregation (table 1). The fact 
that the different amollnts of Ca2* were secreted at 
the same relative velocity (constancy of k2, [25]), 
suggests that the extent of secretion solely depended 
on the energy state of the platelet at the moment of 
platelet-thrombin interaction. When secretion was 
induced at a lower metabolic ATP level, less Ca2” 
was secreted. The relation between the amount of 
Ca2+ secreted and the concomitant consumption of 
metabolic ATP (fig.2 D-F) was linear and the regres- 
sion line passed through the origin, that is, there was 
no ATP consumption in the absence of Ca2+ secretion. 
This suggests that platelets deprived of normal energy 
production direct all available energy to Ca2+ secre- 
tion, probably at the expense of the many energy 
consuming processes that are occurring in the resting 
cell. 
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